FaunaBio
Michael F. Geremia serves as the Senior Vice President of Finance & Operations at Fauna Bio since July 2024, contributing to corporate strategy and fundraising initiatives while acting as a strategic partner to the executive leadership team. Previously, Michael has held significant roles including Member of the Board of Directors at Narwhal Bio Inc. and Senior VP of Finance & Operations at Ocelot Bio, which is involved in a Phase 2 clinical trial for severe liver disease treatment. Other notable positions include Head of Finance at SleepScore Labs, Vice President of Finance at Roswell Biotechnologies, and CFO at Vala Sciences, where Michael supported cutting-edge biotech and imaging technology developments. Earlier career experience includes founding AirCycle and serving as Director of Finance at Mission Pools, where financial oversight was provided for a multi-million dollar firm. Michael holds an M.B.A. in Business Entrepreneurship and a BBA in Finance from San Diego State University.
This person is not in any teams
This person is not in any offices
FaunaBio
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bioleverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.